---
title: Accelerating Preclinical Assessment
description: Pekka Kallunki PhD Principal Scientist at Lundbeck discusses AI models for quantifying alpha-synuclein and the benefits of AI in preclinical analysis.
image: https://www.aiforia.com/hubfs/Website%20Assets/Webinars%20LP%20thumbnails/WebThumb_Lundbeck_Accelerating%20preclinical%20assessment.png
---

![](https://www.aiforia.com/hubfs/Avidly2020_Theme_assets/anime/Neural-network-complex-image.svg)

# On-demand Webinar Accelerating preclinical assessment

Using artificial intelligence for the quantitative assessment of alpha-synuclein pathology.

 

Topics discussed:

- Developing AI models with Aiforia Create for quantifying alpha-synuclein in brain tissue
- Benefits of using deep learning AI in preclinical analysis
- Introduction and live demo of Aiforia

## Speakers

![Pekka Kallunki](https://www.aiforia.com/hs-fs/hubfs/Website%20Assets/Speaker%20Images/Pekka%20Kallunki.png?width=150&name=Pekka%20Kallunki.png)

**Pekka Kallunki PhD** Principal Scientist at Lundbeck A/S

![Hanna-Kaisa Sihvo 2](https://www.aiforia.com/hs-fs/hubfs/Website%20Assets/Team%20Portraits/Hanna-Kaisa%20Sihvo%202.jpg?width=150&name=Hanna-Kaisa%20Sihvo%202.jpg)

**Hanna-Kaisa Sihvo DVM PhD Dipl ECVP** Senior Scientist at Aiforia

## Watch the on-demand webinar!

On-demand webinar

## Accelerating preclinical assessment

Pekka Kallunki Principal Scientist at Lundbeck: "Accelerating preclinical assessment"

00:55

Introduction to Aiforia

28:04

Live demo of the Aiforia software

35:35

Q&A

44:24

 Your browser does not support the video tag.

Questions? Want to book a demo with one of our experts?

## Contact us!